| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arch Therapeutics, Inc. | Director | Warrants (right to buy) | 20,584 | 31 Aug 2023 | Drake Partners | ||
| Arch Therapeutics, Inc. | Director | Common Stock | 10,292 | 31 Aug 2023 | Drake Partners |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARTHQ | Arch Therapeutics, Inc. | 31 Aug 2023 | 2 | +$2,830 | 4 | Director | 08 Sep 2023, 17:47 |
| ARTHQ | Arch Therapeutics, Inc. | 10 Nov 2022 | 1 | $0 | 4 | Director | 10 Nov 2022, 20:51 |
| ARTHQ | Arch Therapeutics, Inc. | 06 Jul 2022 | 3 | $0 | 4 | Director | 08 Jul 2022, 16:53 |
| ARTHQ | Arch Therapeutics, Inc. | 27 Sep 2021 | 1 | $0 | 4 | Director | 13 Oct 2021, 06:03 |
| ARTHQ | Arch Therapeutics, Inc. | 27 Sep 2021 | 0 | $0 | 3 | Director | 12 Oct 2021, 21:23 |